- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05004662
Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
Partnering With a State Food Bank to Provide Tobacco Treatment to Underserved Smokers (Project NOURISH)
This study evaluates the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≥100 lifetime cigarettes
- English or Spanish speaking
- Currently smoke ≥5 cigarettes/day
- Process a smartphone compatible with the project app
- Have a valid email address
- Receipt of food assistance in the past 3 month
Exclusion Criteria:
- Currently pregnant or breastfeeding
- Current use of smoking cessation medications
- Enrolled in a smoking cessation study
- Household member enrolled in the study
- Failure to electronically confirm participation with 14 days of randomization via electronic link sent to participant's smartphone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Treatment
Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment. |
Participants were provided with a 10-week supply of nicotine patches Smoking cessation treatment delivery by State Quitline's Participants were provided with a 10-week supply of nicotine lozenges |
|
Experimental: Automated Treatment
Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content. |
Participants were provided with a 10-week supply of nicotine patches Participants were provided with a 10-week supply of nicotine lozenges An interactive smartphone-based intervention that comprises content delivered via audio/video clips and text content automatically each week for 12 weeks and on demand for 26 weeks to participants |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Reported 7-Day Point-Prevalence Smoking Abstinence
Time Frame: 12 Month Follow-Up
|
Participants who report no smoking, not even a puff, within the past 7 days |
12 Month Follow-Up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemical Verification Via Salivary Cotinine
Time Frame: 12 Month Follow-Up
|
Investigators will biochemically verify smoking status by collecting cotinine samples via salivary cotinine kit |
12 Month Follow-Up
|
|
Self-Reported 24-Hour Point-Prevalence Smoking Abstinence
Time Frame: 12 Month Follow-Up
|
Number of participants who report no smoking, not even a puff, within the past 24 hours |
12 Month Follow-Up
|
|
Self-Reported 30-Day Point-Prevalence Smoking Abstinence
Time Frame: 12 Month Follow-Up
|
Number of participants who report no smoking, not even a puff, within the past 30 days |
12 Month Follow-Up
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Damon J Vidrine, Dr.PH, Moffitt Cancer Center
- Principal Investigator: Jennifer I Vidrine, Ph.D., Moffitt Cancer Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCC-20154
- R01CA231952 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.